# FDA 483 - Gemini Pharmaceuticals, Inc. - July 26, 2022

Source: https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/ece92446-1406-489e-aeac-8758665dd9f7

> FDA 483 for Gemini Pharmaceuticals, Inc. on July 26, 2022. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Gemini Pharmaceuticals, Inc.
- Inspection Date: 2022-07-26
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: An FDA inspection of Gemini Pharmaceuticals, Inc. in Commack, NY, revealed a significant deficiency in their manufacturing processes. The firm failed to verify that finished batches of dietary supplements met product specifications for identity, purity, strength, and composition. This was specifically noted by the absence of finished product testing for several dietary supplement products.

## Related Documents

- [483 - 2011-06-01](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/d3335f63-f681-4529-a490-7f5be013903e)
- [483 - 2015-06-30](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/355d3e31-f50a-4ffb-8c27-5cb4b6411eb3)
- [483 - 2018-02-16](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/563a968e-94b3-45dd-b4f5-b8039e638982)

## Related Officers

- [investigator](https://www.keypedia.com/people/christopher-s-fields/066519e8-20eb-4c41-aaf6-5b17348a0409)

Company: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961